A firefly luciferase (FLuc) counts among the most popular reporters of present-day molecular and cellular biology. In this study, we report a cryptic promoter activity in the luc+ gene, which is the most frequently used version of the firefly luciferase. The FLuc coding region displays cryptic promoter activity both in mammalian and yeast cells. In human CCL13 and Huh7 cells, cryptic transcription from the luc+ gene is 10-16 times weaker in comparison to the strong immediate-early cytomegalovirus promoter. Additionally, we discuss a possible impact of the FLuc gene cryptic promoter on experimental results especially in some fields of the RNA-oriented research, for example, in analysis of translation initiation or analysis of miRNA/siRNA function. Specifically, we propose how this newly described cryptic promoter activity within the FLuc gene might contribute to the previous determination of the strength of the cryptic promoter found in the cDNA corresponding to the hepatitis C virus internal ribosome entry site. Our findings should appeal to the researchers to be more careful when designing firefly luciferasebased assays as well as open the possibility of performing some experiments with the hepatitis C virus internal ribosome entry site, which could not be considered until now.
INTRODUCTION
A firefly luciferase (FLuc) from the common North American firefly Photinus pyralis is very popular nowadays as a very sensitive reporter with an extraordinarily broad dynamic range of the measurable activity. The sensitivity, versatility, and relative simplicity of the luciferase-based assays are the reasons why FLuc ranks among the most frequently used reporter genes and as such has been used in thousands of variously designed experiments since the time of its first discovery for application in molecular and cellular biology (de Wet et al. 1987) . The broad use of firefly luciferase in research laboratories and for diagnostic purposes was further facilitated by the effort of Promega Corporation that introduced a variety of products designed to simplify and to improve luciferase-based assays. Among these improvements, Promega introduced a version of the firefly luciferase gene (luc+) in the pGL3 plasmid series (Groskreutz et al. 1995 ) that has become the most commonly used version at the present time.
Recently, several researchers have revised the published results by finding cryptic promoters or cryptic splicing sites in the genomic fragments that had previously been claimed to bear an internal ribosome entry sites (for review, see Kozak 2003 Kozak , 2005 Baird et al. 2006; Mokrejs˘et al. 2007 ). Generation of unwanted aberrant transcripts by cryptic splicing sites and/or cryptic promoters present in plasmid backbone and their ability to affect the particular assays also have been reported (Boshart et al. 1992; Rosfjord et al. 1994; Hennecke et al. 2001; Hall et al. 2002; Giannakis et al. 2003; Van Eden et al. 2004; Holcik et al. 2005; Kozak, 2007; Makelainen and Makinen 2007) . However, no significant attention has been paid to cryptic transcription from reporter genes until now.
We report here the presence of a cryptic promoter activity in the firefly luciferase gene that is detectable both in yeast and in mammalian cells and that can, due to extremely high sensitivity of the luciferase enzyme assay, seriously affect experimental results. Consistent with this finding, we re-evaluate the published strength of the promoter located in the cDNA sequence corresponding to the internal ribosome entry site of the hepatitis C virus (HCV IRES) (Dumas et al. 2003) . 3 These authors contributed equally to this work. Reprint requests to: Martin Pospís˘ek, Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Vinicna 5, 128 44 Prague, Czech Republic; e-mail: martin@natur.cuni.cz; fax: 420-2-21951724.
Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.831808.
RESULTS
The firefly luciferase luc+ gene displays a cryptic promoter activity both in mammalian and yeast cells During our studies of translation initiation at the hepatitis C internal ribosome entry site ) as well as during our theoretical RNA-oriented research (Mokrejsȇ t al. 2006) , we gained suspicion that the commonly used luc+ version of the firefly luciferase gene contains a promoter that is active in various cells of different organisms. To prove this hypothesis, we decided to take advantage of the pRG vector, which was originally developed for the examination of IRES elements by flow cytometry and fluorescence microscopy in our laboratory . Schematic drawings of all the mammalian vectors used throughout this study including typical results of the corresponding flow cytometry experiments are shown in Figure 1 . The pRG vector (Fig. 1B) contains the red fluorescence protein (DsRED2) gene and the enhanced green fluorescence protein (EGFP) gene as the first and the second reporter cistrons, respectively, and can be used for in vivo production of DsRED2-EGFP bicistronic mRNA under the control of the cytomegalovirus immediateearly (CMV IE) promoter. The promoterless variant of pRG, the pRG(-P) vector (Fig. 1C) , has a reasonably low background of EGFP production and can be used effectively as a tool for detection and analysis of possible cryptic transcription sites located within the inserted intercistronic regions. To test the putative promoter activity of the FLuc protein-coding sequence, we inserted its luc+ version (Promega) between the DsRED2 and EGFP reporter genes of the promoterless backbone, thus creating the pRG(-P)Luc vector ( Fig. 1G,J) . A small portion of the cells transiently transfected with the negative control promoterless pRG(-P) vector still produced basal levels of EGFP (Fig. 1C) . We succeeded in eliminating even this basal production of green fluorescence protein by insertion of the L270 fragment into the intercistronic region. The L270 fragment (IRESite ID 97; http://www.iresite.org) is a short DNA sequence (270 nt) containing a small open reading frame. L270 has been selected from the l phage DNA library in our previous work for its ability to significantly prevent measurable nonspecific translation of the 39-cistron from bicistronic mRNA probably by blocking a ribosome readthrough from the 59 to the 39 cistron ).
The resulting pRG(-P)L270 vector shows no detectable levels of EGFP production under the experimental conditions described herein and was used to adjust the system baseline of all the measurements (Fig. 1I,L) . As a positive control of cryptic promoter activity, we used the cDNA corresponding to the hepatitis C internal ribosome entry site (1 to 385 nt of the HCV 1a genome) (Fig. 1H,K) . In all the flow cytometry experiments, the pEGFP-N1 vector (Clontech) was used both for setting gates for EGFPproducing green fluorescent cells as well as a positive control for measurement of the CMV IE promoter strength (Fig. 1A) . To gate the signal from the red fluorescence protein, we used the pRG vector itself (Fig. 1B) . The two promoterless pRG(-P)-based vectors containing either the FLuc gene (Fig. 1G,J) or HCV IRES cDNA (Fig. 1H,K) in the intercistronic region clearly show their cryptic promoter activity, and thus their ability to drive an expression of EGFP in transfected cells. Figure 2A and Table 1 summarize the results of six independent biological replications aimed to determine the strength of the possible promoter activity within both the luc+ gene and the HCV IRES cDNA. The promoter activity was calculated as a mean of green fluorescence of all the gated EGFP-positive cells. It is clear that both sequences contain the promoter displaying some 16 times lower activity in comparison to the strong immediate-early CMV promoter. Relatively high green fluorescence in pRG(-P)-transfected cells ( Fig. 2A) is probably a result of some rare events of nonspecifically expressed EGFP that might be caused, for example, by accidental vector reorganization, its integration into the host genome, or by some rare and weak transcription initiation within the vector backbone. This statement is supported by flow cytometry analysis depicted in Figure  1C , which shows just a few cells (0.31% in average of eight experiments) possessing green fluorescence among the cells transfected with pRG(-P). Furthermore, total EGFP production from the promoterless pRG(-P) control vector normalized to the number of cells subjected to analysis is comparable to background in appearance (Fig. 2B ). Compared to that, the positive control vector pEGFP-N1 gives 57.21% of green fluorescent cells in an average of 11 experiments (Fig. 1A ). The value of 57.21% of positive green fluorescent cells transfected with the control pEGFP-N1 vector represents also the average transfection efficiency in all the experiments. Throughout the whole study, we used epithelial CCL13 cells, also referred to as Chang cells. However, similar results were obtained also with Huh7 liver cells (Fig. 1J -L) except that the average transfection efficiencies were 44% under the described conditions.
To prove the cryptic promoter activity of the luc+ gene in another context, we prepared the new pFG vector, where the CMV IE promoter is directly followed by downstream FLuc and EGFP genes, as well as its promoterless variant pFG(-P), containing only FLuc followed by EGFP. Typical results obtained by flow cytometry of CCL13 cells transiently transfected with pFG and pFG(-P) vectors are depicted in Figure 1 , E and F, and Figure 2B . Contrary to Figure 2A depicting the calculated mean of green fluorescence of every EGFP gated (positive above the set threshold) cell, Figure 2B represents total EGFP fluorescence normalized to 50,000 cells transfected with pEGFP-N1, pRG, pRGLuc, pFG, and their promoterless variants. The results are shown after subtraction of autofluorescence of untransfected CCL13 cells and clearly point to negligible EGFP production from the promoterless pEGFP-N1(-P) vector. This result is consistent with fractionally measurable activity of luciferase in pFG(-P) and pRGLuc ( Fig. 2B ) and no detectable red fluorescence in pRG(-P) (data not shown) containing cells, and clearly demonstrates no or negligible transcription from plasmid backbones. The significant amount of EGFP produced in cells transfected with promoterless pFG(-P) vector thus gives another strong evidence for the cryptic promoter activity within the FLuc gene (Fig. 2B ). The strength of the FLuc cryptic promoter appears to be only less than 10 times lower than the activity of the strong CMV IE promoter in this assay. Assaying luciferase activity in transfected cells also answered the question of whether the shorter transcripts generated from the FLuc cryptic promoter can be translated to enzymatically active polypeptides. A significant amount of active luciferase was detected only in cells containing the fulllength luciferase gene under the control of the CMV IE promoter, while cells transfected with the promoterless pFG(-P) vector displayed almost no luciferase activity (Fig. 2B) .
To support the sensitive reporter assays described above with RNA data, we analyzed the presence of transcripts complementary to the FLuc-coding region by Northern blotting and real-time qRT-PCR. The autoradiogram in Figure 3A represents Northern blots of poly(A) + -enriched RNA isolated from CCL13 cells transfected either with pRG or with pRGLuc and/or with their promoterless variants. Membranes were probed with 32 P-labeled ssRNA probes against either 59 or 39 FLuc gene ends, respectively. Both probes produce strong signals against the samples prepared from cells transfected with CMV promoter-containing vectors; however, only the probe complementary to the 39 FLuc end (nucleotides 1411 -1634) is capable of hybridizing with mRNA isolated from cells transfected with the promoterless pRG(-P)Luc vector. We carried out several Northern blot experiments with either total RNA or mRNA samples, but every time obtained diffuse signals instead of expected discrete bands. Mapping of possible cryptic transcription sites within the 1653-bp-long luc+ coding region by semiquantitative RT-PCR (data not shown) and real-time qRT-PCR (Fig. 3B,C ) surprisingly also exhibits no strictly localized transcription site but, rather, a progressively increasing amount of transcripts in the 59-to-39 direction of the FLuc gene. Figure 3B demonstrates an example of qRT-PCR analysis in which amplicons of similar length uniformly distributed along the luc+ transcript were quantified. The observed difference of five-threshold-cycle (C t ) between the amplicons corresponding to very 59-end and very 39-end of the FLuc coding region thus reflects a 32 times increase of the relative transcript copy number. Figure  3C shows mapping of the transcription activity borne within the luciferase-coding region in more detail. Two independent real-time qRT-PCR experiments were done with 29 combinations of primers covering the whole Fluc and part of the EGFP genes of the pRG(-P)Luc vector. The results also display the same trend of gradually increased transcription from 59-to 39-ends and are in agreement with Northern blot analysis displaying a diffuse signal rather than distinct bands. The observed gradual increase of C t values along the luc+ CDS should not be influenced by possible cryptic transcription from the opposite strand as well as by the presence of RNA degradation species because an EGFPgene-specific primer and poly(A) + mRNA fraction were used for cDNA synthesis. We propose that the combination of qRT-PCR and Northern blotting data reflects the real situation in cells, where the transcription from several cryptic promoters scattered along the luciferase-coding region is followed by intensive degradation of aberrant transcripts. The firefly luciferase is a ubiquitously used reporter gene. Therefore, we tested the possible promoter activity in the protein coding region of its most frequently used variant luc+ also in one of the most popular eukaryotic model organisms-in the budding yeast Saccharomyces cerevisiae. For this purpose we utilized the yeast pFGAL4h vector ) originally designed for in vivo production of bicistronic mRNAs bearing the luc+ gene as the first and GAL4 as the second cistron. To test and measure the possible promoter activity of the luc+ gene, we deleted the strong TPI promoter from the 59-end of the bicistronic transcription unit and thus prepared a promoterless pFGAL4h(-P) vector (Fig. 4A) . Luminescence measurements show a marked drop of the FLuc activity in cells carrying this promoterless pFGAL4h(-P) vector, while the second Gal4 reporter protein remained synthesized, which clearly confirms the activity of the internal luc+ cryptic promoter in yeast as well (Fig. 4B) . To prove the observed cryptic promoter activity by Northern blotting, we prepared a new vector (pYX213Luc) containing the FLuc gene under the control of a tightly regulated yeast GAL1 promoter. Northern blot analyses revealed that the radiolabeled ssRNA probe complementary to the 59-end of the FLuc gene gives a strong signal only with total RNA isolated from yeast harboring the pFGAL4h vector and/or from yeast containing pYX213Luc and growing on galactose. Contrary to that, the probe complementary to the 39-end of the FLuc gene (nucleotides 1411 -1634) revealed additional shorter transcripts originating from the luciferase-coding region both in yeast transformed with the promoterless variant of the pFGAL4h vector as well as in yeast containing pYX213Luc but growing on glucose, which tightly repressed transcription from the GAL1 promoter. Measurement of the FLuc promoter activity and Northern blotting point to significantly high activity of cryptic transcription starting from several cryptic transcription initiation sites within the luc+ coding region in yeast. Reevaluation of the cryptic promoter activity in cDNA of the HCV IRES Michel Ventura's group (Dumas et al. 2003) reported recently that a cDNA fragment corresponding to the hepatitis C virus internal ribosome entry site possesses cryptic promoter activity in human hepatoma cell lines HepG2 and Huh7. We proved this finding in the Huh7 cells and further have shown this activity also in the CCL13 (HeLa) human epithelial cells. However, by careful and exhaustively repeated measurements of the HCV IRES promoter strength, we found it to be much weaker both in CCL13 and Huh7 cell lines (Figs. 1H,K, 2A ; Table 1 ) than previously thought. One explanation of such a discrepancy could be-at least in part of Ventura's experiments-in their promoterless vector design, where FLuc as the 59-reporter directly preceded HCV IRES and the following 39-reporter (Renilla luciferase and/or EGFP). In such constructs, the final level of the 39-reporter transcription will be a result of combined action of the two cryptic promoters, the HCV IRES promoter and the FLuc promoter described herein. Other technical reasons including differences in equipment settings might also contribute to the observed differences in measured strength of the cryptic promoter localized within the HCV IRES cDNA.
DISCUSSION
We present here clear evidence that the luc+ variant of the firefly luciferase gene contains a cryptic promoter site, which is active both in human cells and yeast. Additionally, both in yeast and human cells, we found a gradual increase of cryptic transcription along the luc+ coding region reflecting an existence of several transcription initiation sites. In mammalian cells, the observable cryptic transcription from the luciferase-coding region increases total EGFP production (normalized to 50,000 cells) from promoterless luc+ containing vectors 97.5 times for the pRG(-P)Luc and 2650 times for pFG(-P) when using pRG(-P) and pEGFP-N1(-P) promotor-less vectors as negative controls, respectively (Fig. 2B) . From another point of view, the cumulative FLuc cryptic promoter is 10 to 16 times weaker than the strong immediate-early promoter from human cytomegalovirus, depending on the vectors used or on the method of statistical evaluation of the obtained data. There is almost no difference between absolute normalized values of EGFP production from pFG(-P) and pRG(-P)Luc vectors (Fig. 2B) ; thus the higher variance in relative increase of luc+ promoter activity measured by these two vectors is due to the difference of background EGFP production from their negative control vectors-pEGFP-N1(-P) and pRG(-P), respectively. Deletion of the CMV IE promoter from all the vectors almost eliminates translation of the first cistron, suggesting almost no transcription from the pEGFP-N1 plasmid backbone [see Fig. 2B , EGFP fluorescence in pEGFP-N1(-P) and luciferase activity in pFG(-P)]. It thus appears that there probably could be a very weak cryptic transcription coming also from the DsRED2 reporter. However, quite high production of EGFP from the pRG vector is probably, rather, a result of the ribosome read-through, which becomes clear after its comparison with EGFP production from promoterless pRG(-P) (Fig. 2B) . In these two constructs, the DsRED2 and EGFP genes are separated by a 69-nt-long spacer that is short enough to allow measurable read-through ( Fig. 3B ; Rajkowitsch et al. 2004; Mas˘ek et al. 2007) . Such a small difference in EGFP production can be observed only in a well-controlled experiment when determining total normalized EGFP fluorescence after subtraction of empty cells' autofluorescence. Contrary to that, calculating the EGFP mean fluorescence only from cells exhibiting some EGFP signal above threshold gives us, in our opinion, better reproducibility and more precise measurement in higher values, but can be influenced by just several incidentally fluorescent cells, as can be seen in the results of the pRG(-P) vector depicted in Figure 1C and a corresponding column in Figure 2A . The problems with ribosome readthrough and possible low cryptic transcription from the DsRED2 gene in the pRG vector series led us to use the pRG(-P)L270 vector, containing an artificial translationblocking intercistronic sequence, as one of the controls in our flow cytometry experiments.
Generation of several types of aberrant transcripts also raised a question about their translatability and possible formation of truncated FLuc-EGFP fusion proteins. The luciferase-coding region contains additional 27 AUGs, 53 termination codons, and 11 short open reading frames, suggesting a low probability of production of significantly long polypeptide by efficient translation of shorter transcripts. Similarly, it is very unlikely that higher EGFP expression can be accounted for by translation of some fusion proteins because of different reading phases of FLuc and EGFP genes in all used plasmids. As it is clearly seen from Figure 2B , the only vector causing appearance of significant FLuc activity in transfected cells is pFG containing FLuc as the first cistron and an intact CMV IE promoter. The bioinformatical analysis of the FLuc coding region together with obtained data showing a gradual increase in transcripts from 59-to 39-FLuc ends led us to speculate that an increase of EGFP expression reflects only translation of transcripts originating from the end of the luciferasecoding region. This presumption is in agreement with the fact that the last AUG is located in position 1477, which closely precedes the transcription initiation start from the predicted SP1 transcription factor binding site (FunSiteP2.1; http://compel.bionet.nsc.ru/). If this is true, the activity of cryptic transcription from the luc+ gene in the sense of production of aberrant transcripts is much higher than could be estimated from indirect measurements of protein reporter production.
The firefly luciferase gene is often utilized for preparation of reporter vectors designed for precise and wellcontrolled transcription of the reporter mRNA in vivo. Typical research areas where the results of luciferase assays are prone to be affected by our findings are those focused on miRNA/siRNA, translation initiation, mRNA polyadenylation, the nonsense-mediated mRNA decay, the 39-UTR-mediated control of gene expression and mRNA stability, and, of course, those aimed toward determination of promoter strength.
An example of possible influence of cryptic promoter activity within the FLuc region on the measured data provided herein is the measurement of cryptic promoter strength in HCV IRES cDNA presented by Dumas et al. (2003) , and by us herein. The high popularity of the FLuc reporter in miRNA/siRNA-oriented research as well as the availability of the commercial systems dedicated to the miRNA analysis led us to hypothesize that the cryptic promoter activity located in the FLuc gene can also influence experimental results obtained in this field. Function and activity of miRNAs and siRNAs are often detected by mRNA containing the FLuc reporter gene and one or multiple target sequences located either in the 39-untranslated region or between the two reporter cistrons of the bicistronic mRNA or even directly within the FLuc coding region (e.g., Boutla et al. 2003; Yi et al. 2003; Cheng et al. 2005; Rehwinkel et al. 2005; Wu et al. 2005; Martin et al. 2006; Lytle et al. 2007; Martin et al. 2007) . Systems for sensitive analysis of microRNA activity based on the FLuc gene and insertion of miRNA-binding sites into its 39-UTR are also offered by several companies including pMIR-REPORT from Ambion. We propose that in such an experimental setup, the presence of the promoter within the FLuc coding sequence may result in additional production of shorter mRNAs that do not code for the functional luciferase enzyme but still function as miRNA/siRNA targets and can titrate out some portion of the examined miRNA/siRNA. Under the usual experimental circumstances when the system is oversaturated with tested mRNAs and miRNAs/ siRNAs, production of such shorter mRNAs might not change the qualitative answer from the experimental data but certainly will affect the absolute values. Care should be especially taken when the experiment is carried out under more natural conditions either when low levels of tester mRNA production in vivo or low amounts of miRNA/ siRNA for direct transfection are used (see, e.g., Boutla et al. 2003) . In our opinion, direct evidence of the possible influence of the FLuc cryptic promoter on the experimental data in miRNA research came out recently through the work of Lytle et al. (2007) , who studied the effect of positional changes of let-7a miRNA-binding sites in an mRNA target on its translational repression. In an attempt not to oversaturate the system, they ''took care to use the lowest possible amount of DNA or RNA in each transfection.'' They found that the presence of miRNA-binding sites led to translational repression regardless of whether or not they are located in the 59-UTR or the 39-UTR of the FLuc-containing monocistronic mRNA-with one exception. They found no repression in the case when the FLuc reporter mRNA contained the miRNA-binding site in the 39-UTR and was produced in vivo after DNA plasmid transfection. Curiously, repression of the similarly designed mRNA was obtained after direct RNA transfection into the cell. Furthermore, the repression also reappeared when the plasmid DNA was electroporated into the cell instead of using common liposome-mediated transfection. Liposomemediated transfection is known to induce an expression of a number of the cellular genes (Calvin et al. 2006) . We therefore assume that the cationic lipid transfection protocol used by Lytle et al. (2007) influenced the analysis of miRNA function by enhancement of cryptic promoter activity within the FLuc coding region.
Our findings as well as other reports about the unexpected transcription from cryptic or unusual sites are consistent with the current view on the eukaryotic transcription when most of the genome is transcribed and many parts of it can serve as unconventional transcription starts (ENCODE Project Consortium et al. 2007; Greally 2007) . Experiments carried out in yeast are especially prone to be affected by cryptic transcription because Saccharomyces cerevisiae can use very short and simple sequences to initiate transcription from both regular and unconventional promoters (Robinson and Lopes 2000; Hellen and Sarnow 2001; Hecht et al. 2002) . Such findings should also appeal to the researchers to consider the possibility of cryptic transcripts generated from plasmid backbones and reporter genes in all cases when possible aberrant transcripts may have a potential to influence the results of the planned experiments.
MATERIALS AND METHODS

Plasmid constructs
The pEGFP-N1 vector was obtained from Clontech. The pRG vector is a bicistronic derivative of pDsRed2-C1 (Clontech) containing the DsRED2 gene and EGFP gene as the first and the second cistrons, respectively, under the control of the cytomegalovirus immediate-early promoter. Construction of pRG and pRGL270 vectors were described previously ). Promoterless vectors [pRG(-P) and pFG(-P)] and their derivatives were prepared by excising the VspI/NheI fragment containing the CMV IE promoter, filling in the recessed 39-termini by the Klenow fragment of the DNA polymerase I and by subsequent re-ligation of blunt-ended vector. The Photinus (firefly) luciferase cassette was amplified from the pGL3-Basic plasmid (Promega) with the forward primer (59-GCGTCGACCATGGAAGACGCCAAAAAC-39) and the reverse primer (59-ACGGATCCTTACACGGCG ATCTTTCCG-39) containing SalI and BamHI restriction sites, respectively. The whole-length HCV IRES sequence from the HCV1a genotype (bases 1-385) was amplified from the vector p90HVCFL (courtesy of Charles Rice) with the forward primer (59-AAAGTCGACGCCAGCCCCCTGATGGGGGCGACAC-39) and the reverse primer (59-ACGGATCCGTGTTACGTTTGGTTT TTCTTTGAGGTTTAGG-39) again containing SalI and BamHI restriction sites, respectively. Both cassettes were inserted into the SalI and BamHI sites of the pRG(-P) vector to create pRG(-P)Luc and pRG(-P)IRES vectors, respectively. To create pRGLuc and pFG vectors, the firefly luciferase cassette was excised from the pRG(-P) vector using SalI and BamHI restriction endonucleases and inserted into the SalI and BamHI sites of pRG and pEGFP-N1 vectors (Clontech), respectively. The yeast pFGAL4h vector was described previously ). To create its promoterless variant pFGAL4h(-P), the triose isomerase promoter (TPI) sequence was removed by AatII and NcoI, and the vector was circularized by ligation with oligonucleotide cassette 59-CAATTA ACCCTCACTAAAGGGAAAGATCTC-39 containing a unique BglII site. The insertion of the FLuc coding region under the control of the galactose-inducible GAL1 promoter was carried out in the pYX213 vector (Ingenius) using NcoI and AvrII restriction enzymes. All clones were verified by restriction endonuclease digestion and sequencing.
Cell cultures, DNA transfection, and flow cytometry analysis
The human epithelial cell line CCL13 (also known as Chang cells) and human hepatoma cell line Huh7 were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 2 mM L-glutamine, 100 iu/mL penicillin, 100 mg/mL streptomycin, and 10% fetal bovine serum (GIBCO) at 37°C in 5% CO 2 and 95% relative humidity. For transient transfections, cells were plated in 24-well tissue culture plates 24 h before transfection. For the standard flow cytometry analysis, cells were transiently transfected under conditions recommended by the manufacturer by the mixture of 1 mg of DNA in 100 mL of 100 mM NaCl and 3.9 mL of ExGen transfection reagent (Fermentas) per well. Fortyeight hours after transfection, the cells were collected by trypsinization and resuspended in DMEM to 10 6 cells per mL. Samples were analyzed by flow cytometry using a BD LSRII device and a Coherent Sapphire 488-20 DPSS laser to excite cells at 488 nm, a 530/30 nm bandpath filter to detect EGFP, and a 585/ 42 nm bandpath filter to detect DsRED2 expression. For RNA analysis, the CCL13 cells were seeded 24 h before transfection in a T-75 flask. Transfection was carried out according to the manufacturer's guidelines. The plasmid DNA (40 mg) was diluted in 150 mM sodium chloride to a final volume of 800 mL, vortexed, centrifuged, and mixed with 7 equivalents (103 mL) of ExGen transfection reagent (Fermentas). Forty-eight hours after transfection, the cells were washed once with 10 mL of PBS and subjected to lysis as described further.
The PJ69-4A S. cerevisiae strain (MATa, 112, gal4D , gal80D, GAL2-ADE2, LYS2TGAL1-HIS3, met2TGAL7-lacZ) (James et al. 1996) was used for all analyses of transcriptional activity with the pFGAL4h vector series. Experiments with derivatives of pYX213 vectors were carried out in the standard W303-1a S. cerevisiae strain (MATa, 112, 15) .
RNA isolation, Northern blot, and real-time qRT PCR analysis
Human cells were disrupted by an RNA-DNA stabilization reagent (Roche). The mRNA Isolation Kit for Blood and Bone Marrow (Roche) was used to isolate poly(A) + mRNA. DNase treatment and inactivation were carried out by the DNA-Free kit (Ambion) following the manufacturer's instructions. Yeast total RNA was isolated by TRI reagent (Sigma) and acid-washed glass beads in order to improve the cell disruption. Either 500 ng of mRNA or 15 mg of total RNA were run on a 1% agarose gel according the protocol described in Mas˘ek et al. (2005) .
32 Plabeled antisense ssRNA hybridization probes displaying complementarity to luc+ CDS in regions 3-392 and 1411-1634 bp were synthesized using the T7 RNA transcription kit (Fermentas). Hybridization was carried out in Dig Easy Hyb solution according to Roche's instructions. Poly(A) + mRNA isolated from 8 3 10 4 cells and an EGFP gene-specific primer (59-GCCGTAGGTCAGG GTGGT-39) were used for cDNA synthesis with SuperScript II RNaseH À reverse transcriptase (Invitrogen). Two microliters of reverse transcriptase reaction were subjected to PCR amplification (15 min at 95°C; then 40 cycles of 30 sec at 94°C; 30 sec at 54°C; 1 min at 68°C; and finally, 4 min at 72°C) using a LightCycler 1.5 (Roche) and QuantiTect SYBR Green PCR kit (QIAGEN). Control reactions without reverse transcriptase were used in parallel to check that there was no significant DNA contamination in the mRNA samples.
Luciferase and b-galactosidase assays
The Gal4 reporter used throughout this study is a specific transcription factor that activates transcription of the particular secondary reporters in specially engineered yeast strains. The complete description of this reporter system as well as methods of assaying both firefly luciferase and b-galactosidase activities with respective luminescent substrates were described previously ). Determination of protein concentration in yeast cell lysates was carried out in triplicate using the Bradford reagent (Sigma) and the microplate reader SpectraMax 340PC (Molecular Devices) following the manufacturers' recommendations. Mammalian cells lysates were prepared by adding the Passive lysis buffer (Promega) to the pelleted cells. Firefly luciferase activity was quantified in quadruplicate with the Luciferase Assay System (Promega) according to the manufacturer's instructions. Microlite TLX2 Dynatech Luminometer was used for all luminescence measurements.
